RASSF1 and hepatocellular carcinoma: Using another panel consisting of SFRP1, GSTP1 and RASSF1A genes, it was shown that presence of the methylated promotor region could accurately differentiate HCC cases from controls with 81.9% specificity and 92.7% sensitivity [72].